GLAXOSMITHKLINE PLC | CIK:0001131399 | 3

  • Filed: 3/20/2018
  • Entity registrant name: GLAXOSMITHKLINE PLC (CIK: 0001131399)
  • Generator: Donnelley Financial Solutions
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1131399/000119312518088407/0001193125-18-088407-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1131399/000119312518088407/gsk-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001131399
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory

    17. Property, plant and equipment

     

               Plant,              
         Land and     equipment     Assets in        
         buildings     and vehicles     construction     Total  
         £m     £m     £m     £m  

    Cost at 1 January 2016

         7,305       10,775       2,670       20,750  

    Exchange adjustments

         956       1,100       271       2,327  

    Other additions

         117       384       1,043       1,544  

    Capitalised borrowing costs

         —         —         30       30  

    Disposals and write-offs

         (349     (1,422     (53     (1,824

    Reclassifications

         110       512       (761     (139

    Transfer to assets held for sale

         (378     (114     (32     (524
      

     

     

       

     

     

       

     

     

       

     

     

     

    Cost at 31 December 2016

         7,761       11,235       3,168       22,164  

    Exchange adjustments

         (127     (62     (45     (234

    Other additions

         69       296       1,219       1,584  

    Capitalised borrowing costs

         —         —         30       30  

    Disposals and write-offs

         (376     (685     (31     (1,092

    Reclassifications

         602       1,186       (1,826     (38

    Transfer to assets held for sale

         (462     (219     (14     (695
      

     

     

       

     

     

       

     

     

       

     

     

     

    Cost at 31 December 2017

         7,467       11,751       2,501       21,719  
      

     

     

       

     

     

       

     

     

       

     

     

     

    Depreciation at 1 January 2016

         (2,914     (7,415     —         (10,329

    Exchange adjustments

         (377     (717     —         (1,094

    Charge for the year

         (338     (640     —         (978

    Disposals and write-offs

         205       1,270       —         1,475  

    Transfer to assets held for sale

         165       92       —         257  
      

     

     

       

     

     

       

     

     

       

     

     

     

    Depreciation at 31 December 2016

         (3,259     (7,410     —         (10,669

    Exchange adjustments

         50       110       —         160  

    Charge for the year

         (299     (689     —         (988

    Disposals and write-offs

         158       539       —         697  

    Transfer to assets held for sale

         314       190       —         504  
      

     

     

       

     

     

       

     

     

       

     

     

     

    Depreciation at 31 December 2017

         (3,036     (7,260     —         (10,296
      

     

     

       

     

     

       

     

     

       

     

     

     

    Impairment at 1 January 2016

         (274     (373     (106     (753

    Exchange adjustments

         (45     (37     (11     (93

    Disposals and write-offs

         91       135       35       261  

    Impairment losses

         (135     (117     (6     (258

    Reversal of impairments

         38       38       2       78  

    Transfer to assets held for sale

         46       10       22       78  
      

     

     

       

     

     

       

     

     

       

     

     

     

    Impairment at 31 December 2016

         (279     (344     (64     (687

    Exchange adjustments

         8       2       (2     8  

    Disposals and write-offs

         210       104       28       342  

    Impairment losses

         (194     (138     (17     (349

    Reversal of impairments

         7       9       1       17  

    Transfer to assets held for sale

         87       8       11       106  
      

     

     

       

     

     

       

     

     

       

     

     

     

    Impairment at 31 December 2017

         (161     (359     (43     (563
      

     

     

       

     

     

       

     

     

       

     

     

     

    Total depreciation and impairment at 31 December 2016

         (3,538     (7,754     (64     (11,356

    Total depreciation and impairment at 31 December 2017

         (3,197     (7,619     (43     (10,859
      

     

     

       

     

     

       

     

     

       

     

     

     

    Net book value at 1 January 2016

         4,117       2,987       2,564       9,668  
      

     

     

       

     

     

       

     

     

       

     

     

     

    Net book value at 31 December 2016

         4,223       3,481       3,104       10,808  
      

     

     

       

     

     

       

     

     

       

     

     

     

    Net book value at 31 December 2017

         4,270       4,132       2,458       10,860  
      

     

     

       

     

     

       

     

     

       

     

     

     

    The weighted average interest rate for capitalised borrowing costs in the year was 4% (2016 – 3.8%). Disposals and write-offs in the year include a number of assets with nil net book value that are no longer in use in the business.

     

    The net book value at 31 December 2017 of the Group’s land and buildings comprised freehold properties £3,896 million (2016 – £3,887 million), properties with leases of 50 years or more £338 million (2016 – £294 million) and properties with leases of less than 50 years £36 million (2016 – £42 million).

    Included in land and buildings at 31 December 2017 were leased assets with a cost of £630 million (2016 – £590 million), accumulated depreciation of £255 million (2016 – £253 million), impairment of £nil (2016 – £1 million) and a net book value of £375 million (2016 – £336 million). Included in plant, equipment and vehicles at 31 December 2017 were leased assets with a cost of £18 million (2016 – £44 million), accumulated depreciation of £4 million (2016 – £15 million), impairment of £1 million (2016 – £nil) and a net book value of £13 million (2016 – £29 million). Some lease agreements include renewal or purchase options or escalation clauses.

    The impairment losses principally arose from decisions to rationalise facilities and are calculated based on either fair value less costs of disposal or value in use. The fair value less costs of disposal valuation methodology uses significant inputs which are not based on observable market data, and therefore this valuation technique is classified as level 3 of the fair value hierarchy. These calculations determine the net present value of the projected risk-adjusted, post-tax cash flows of the relevant asset or cash generating unit, applying a discount rate of the Group post-tax weighted average cost of capital (WACC) of 7%, adjusted where appropriate for relevant specific risks. For value in use calculations, where an impairment is indicated and a pre-tax cash flow calculation is expected to give a materially different result, the test would be reperformed using pre-tax cash flows and a pre-tax discount rate. The Group WACC is equivalent to a pre-tax discount rate of approximately 9%. The net impairment losses have been charged to cost of sales £198 million (2016 – £45 million), R&D £93 million (2016 – £15 million) and SG&A £36 million (2016 – £120 million), and included £278 million (2016 – £151 million) arising from the major restructuring programmes.

    Reversals of impairment arose from subsequent reviews of the impaired assets where the conditions which gave rise to the original impairments were deemed no longer to apply. All of the reversals have been credited to cost of sales.

    The carrying value at 31 December 2017 of assets for which impairments have been charged or reversed in the year was £33 million (2016 – £171 million).

    During 2017, £38 million (2016 – £139 million) of computer software was reclassified from assets in construction to intangible assets on becoming ready for use.